Kiely E A, Blank M A, Bloom S R, Williams G
Br J Urol. 1987 Apr;59(4):334-9. doi: 10.1111/j.1464-410x.1987.tb04644.x.
Intracavernosal and peripheral venous vasoactive intestinal polypeptide (VIP) levels were measured in men with predominantly organic or predominantly psychogenic impotence. The measurements were taken at intervals up to 30 min following intracavernosal injections of saline, papaverine hydrochloride and papaverine hydrochloride and phentolamine. Levels were also measured after tactile and visual sexual stimulation and following an intravenous injection of papaverine and phentolamine. A penile erection occurred in all men receiving intracavernosal vasoactive compounds. The mean VIP concentration did not alter significantly in either cavernosal or peripheral venous blood during the erection. Mean VIP concentrations were significantly greater in the neurogenic (all diabetic) group than in the other groups studied. Mean cavernosal and peripheral VIP concentrations did not alter following tactile or visual sexual stimulation and no significant alteration in mean peripheral venous VIP concentration occurred following injection of papaverine and phentolamine. The putative role of VIP in the induction of penile erection has not been elucidated in these studies.
对主要患有器质性或心因性阳痿的男性,测量其海绵体内和外周静脉中的血管活性肠肽(VIP)水平。在海绵体内注射生理盐水、盐酸罂粟碱以及盐酸罂粟碱和酚妥拉明后,每隔30分钟进行一次测量。在触觉和视觉性刺激后以及静脉注射罂粟碱和酚妥拉明后,也进行了测量。所有接受海绵体内血管活性化合物注射的男性均出现阴茎勃起。勃起过程中,海绵体或外周静脉血中的VIP平均浓度均未发生显著变化。神经源性(均为糖尿病患者)组的VIP平均浓度显著高于其他研究组。触觉或视觉性刺激后,海绵体和外周VIP的平均浓度未发生变化,注射罂粟碱和酚妥拉明后,外周静脉VIP的平均浓度也未发生显著变化。在这些研究中,尚未阐明VIP在诱导阴茎勃起中的假定作用。